|
|
|||||||||||||||||||||||
Article Navigation
|
Press Release Lorenzen Cancer Foundation Urges Cancer Drug Coverage in the Prescription Drug Benefit Actby: Lorenzen Cancer Foundation Urges Cancer Drug Coverage in the Prescription Drug Benefit Act In the interests of cancer patients and oncologists nationwide, the Lorenzen Cancer Foundation (LCF), a non-profit dedicated to fighting pancreatic cancer, has joined the public interest law firm Washington Legal Foundation (WLF) and others today in presenting a written comments statement to the U.S. Centers for Medicare and Medicaid Services (CMS) voicing support for the Section 641 demonstration project and expressing concerns regarding CMS’s proposed restrictions limiting coverage of the drug benefit to exclude off-label uses of FDA-approved drug or biological therapies. Monterey, CA July 7, 2004 -- In the interests of cancer patients and oncologists nationwide, the Lorenzen Cancer Foundation (LCF), a non-profit dedicated to fighting pancreatic cancer, has joined the public interest law firm Washington Legal Foundation (WLF) and others today in presenting a written comments statement to the U.S. Centers for Medicare and Medicaid Services (CMS) voicing support for the Section 641 demonstration project and expressing concerns regarding CMS’s proposed restrictions limiting coverage of the drug benefit to exclude off-label uses of FDA-approved drug or biological therapies. Latest Cancer News:Hormone drugs for prostate cancer may hurt heart (Reuters via Yahoo! News) Prostate cancer treatments that cut off the supply of male hormone raise cholesterol, worsen blood sugar and make men fatter and thus likely raise the risk of heart attack, too, doctors said on Monday. Auriemma to donate ties on eBay for cancer fund (AP via Yahoo! Sports) Geno Auriemma plans to auction off the neck ties he wears during the rest of UConn's games this season. The school says money raised by the auctions will benefit the Kay Yow/WBCA Cancer Fund. The North Carolina State University women's basketball coach died a year ago after a long fight with breast cancer. Approval Expanded for Breast Cancer Drug Tykerb (HealthDay via Yahoo! News) MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug Administration has expanded approval for Tyberb (lapatinib) to include postmenopausal women with hormone- and HER2-positive advanced breast cancer who require hormone therapy. Cancer, Autism Push By Obama to Spur New Medicines (Update2) (Bloomberg) Feb. 1 (Bloomberg) -- President Barack Obama proposed increasing the National Institutes of Health budget by $1 billion, or 3.2 percent, in fiscal 2011, earmarking $6 billion for cancer research and $222 million for work in autism. Heart Risk From Prostate Cancer Hormone Therapy (WebMD) Androgen-blocking hormone therapy for prostate cancer may raise the risk of heart disease, warns an expert panel representing heart, cancer, and urology organizations. Cancer, Autism Push in Obama Budget Plan to Spur 30 New Drugs (Bloomberg) Feb. 1 (Bloomberg) -- President Barack Obama increased the National Institutes of Health budget proposal by $1 billion, or 3.2 percent, in fiscal 2011, earmarking $6 billion for cancer research and $222 million for work in autism. Targeting Cancer Stem Cells May Eradicate Tumors (MedicineNet.com) Title: Targeting Cancer Stem Cells May Eradicate Tumors Category: Health News Created: 1/29/2010 4:10:00 PM Last Editorial Review: 2/1/2010 Three-Fourths of Cancer Patients Have Severe Flares of Pain (MedicineNet.com) Title: Three-Fourths of Cancer Patients Have Severe Flares of Pain Category: Health News Created: 1/29/2010 12:10:00 PM Last Editorial Review: 2/1/2010 Scammer Allegedly Lies About Cancer (ABC News) Prosecutor says Md. woman lied about terminal cancer to steal money. Cancer - Health - Conditions and Diseases - Organizations - United States Childhood cancer project under way (Chicago Sun-Times) What's touted as the biggest effort ever to find all of the genetic mutations that cause childhood cancer is now under way. The privately funded project will complement the Cancer Genome Atlas,an eight-year National Institutes of Health initiative focusing largelyon adult malignancies, says NIH director Dr. Francis Collins. Standard prostate cancer test faces debate - The Money Times
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org